NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyClinical Trials: Oral Complications of Cancer Therapy (R21)
About This Grant
The NIDCR and NCI invites applications for clinical research directed at reducing the incidence and severity of oral complications from cancer therapies. The development of a Clinical Pilot Data Grants under this FOA would be to collect preliminary data to establish an adequate foundation for a future Phase III clinical trial.
Grant Summary
Clinical Trials: Oral Complications of Cancer Therapy (R21) is a National Institutes of Health grant providing up to $200K for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $200K
Rolling / Open
- 1Confirm your organization is eligible for Clinical Trials: Oral Complications of Cancer Therapy (R21) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Clinical Trials: Oral Complications of Cancer Therapy (R21): Frequently Asked Questions
Who is eligible for the Clinical Trials: Oral Complications of Cancer Therapy (R21)?
Clinical Trials: Oral Complications of Cancer Therapy (R21) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Clinical Trials: Oral Complications of Cancer Therapy (R21) provide?
Clinical Trials: Oral Complications of Cancer Therapy (R21) provides up to $200K per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Clinical Trials: Oral Complications of Cancer Therapy (R21) deadline?
Clinical Trials: Oral Complications of Cancer Therapy (R21) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Clinical Trials: Oral Complications of Cancer Therapy (R21)?
To apply for Clinical Trials: Oral Complications of Cancer Therapy (R21), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.